| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $257,688 | 1 | 6 |
Sells | $142,347,687 | 16 | 94 |
| MORIKIS JOHN G | director | 1 | $257,688 | 0 | $0 | $257,688 |
| Decker Robert J | VP Corporate Controller | 0 | $0 | 1 | $1.01M | $-1.01M |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | 0 | $0 | 1 | $2.41M | $-2.41M |
| Taubert Jennifer L | EVP, WWC. Innovative Medicine | 0 | $0 | 1 | $3.95M | $-3.95M |
| Forminard Elizabeth | EVP, Chief Legal Officer | 0 | $0 | 1 | $4.09M | $-4.09M |
| Broadhurst Vanessa | EVP, Global Corp Affairs | 0 | $0 | 2 | $7.3M | $-7.3M |
| REED JOHN C | EVP, Innovative Medicine, R&D | 0 | $0 | 1 | $7.83M | $-7.83M |
| Schmid Timothy | EVP, WW Chair, MedTech | 0 | $0 | 3 | $12.04M | $-12.04M |
| Swanson James D. | EVP, CIO | 0 | $0 | 2 | $15.11M | $-15.11M |
| Wolk Joseph J | Exec VP, CFO | 0 | $0 | 1 | $21.77M | $-21.77M |
| Duato Joaquin | CEO and Chairman of the Board | 0 | $0 | 3 | $66.84M | $-66.84M |
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, …
Over the last 12 months, insiders at Johnson & Johnson have bought $257,688 and sold $142.35M worth of Johnson & Johnson stock.
On average, over the past 5 years, insiders at Johnson & Johnson have bought $202,454 and sold $64.81M worth of stock each year.
Highest buying activity among insiders over the last 12 months: MORIKIS JOHN G (director) — $257,688.
The last purchase of 1,250 shares for transaction amount of $257,688 was made by MORIKIS JOHN G (director) on 2025‑11‑26.
| 2026-09-02 | Sale | Schmid Timothy | EVP, WW Chair, MedTech | 22,527 0.0009% | $274.74 | $6.19M | -3.22% | |
| 2026-08-17 | Sale | Taubert Jennifer L | EVP, WWC. Innovative Medicine | 15,000 0.0006% | $263.36 | $3.95M | +2.37% | |
| 2026-08-13 | Sale | Duato Joaquin | CEO and Chairman of the Board | 123,291 0.0051% | $261.17 | $32.2M | +2.46% | |
| 2026-08-06 | Sale | Forminard Elizabeth | EVP, Chief Legal Officer | 15,918 0.0007% | $257.00 | $4.09M | +4.15% | |
| 2026-08-05 | Sale | Duato Joaquin | CEO and Chairman of the Board | 48,480 0.002% | $258.15 | $12.52M | +3.90% | |
| 2026-07-20 | Sale | Broadhurst Vanessa | EVP, Global Corp Affairs | 23,054 0.001% | $251.27 | $5.79M | +7.26% | |
| 2026-06-11 | Sale | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 10,000 0.0004% | $241.15 | $2.41M | +10.02% | |
| 2026-02-27 | Sale | Decker Robert J | VP Corporate Controller | 4,075 0.0002% | $247.87 | $1.01M | +1.95% | |
| 2026-02-20 | Sale | Schmid Timothy | EVP, WW Chair, MedTech | 1,322 <0.0001% | $245.66 | $324,763 | +4.17% | |
| 2026-02-18 | Sale | Schmid Timothy | EVP, WW Chair, MedTech | 22,623 0.0009% | $244.33 | $5.53M | +2.69% | |
| 2026-02-17 | Sale | Swanson James D. | EVP, CIO | 20,521 0.0008% | $242.70 | $4.98M | +3.04% | |
| 2026-02-17 | Sale | Broadhurst Vanessa | EVP, Global Corp Affairs | 6,197 0.0003% | $243.39 | $1.51M | +3.04% | |
| 2026-02-17 | Sale | Wolk Joseph J | Exec VP, CFO | 89,654 0.0037% | $242.80 | $21.77M | +3.04% | |
| 2026-02-17 | Sale | REED JOHN C | EVP, Innovative Medicine, R&D | 32,210 0.0013% | $243.00 | $7.83M | +3.04% | |
| 2026-02-13 | Sale | Swanson James D. | EVP, CIO | 41,559 0.0017% | $243.73 | $10.13M | +2.64% | |
| 2026-01-26 | Sale | Duato Joaquin | CEO and Chairman of the Board | 100,000 0.0041% | $221.23 | $22.12M | +11.34% | |
| 2025-11-26 | MORIKIS JOHN G | director | 1,250 <0.0001% | $206.15 | $257,688 | +16.93% | ||
| 2025-10-17 | Sale | REED JOHN C | EVP, Innovative Medicine, R&D | 21,721 0.0009% | $192.71 | $4.19M | +24.64% | |
| 2025-09-04 | Sale | Taubert Jennifer L | EVP, WWC. Innovative Medicine | 56,471 0.0023% | $177.81 | $10.04M | +30.05% | |
| 2025-08-22 | Sale | Duato Joaquin | CEO and Chairman of the Board | 125,824 0.0052% | $179.21 | $22.55M | +29.01% |
| MORIKIS JOHN G | director | 1849 0.0001% | $492,017.91 | 1 | 0 | |
| PRINCE CHARLES | director | 28520 0.0012% | $7.59M | 6 | 0 | +5.18% |
| PEREZ WILLIAM D | director | 16030 0.0007% | $4.27M | 14 | 0 | +2.65% |
| MULCAHY ANNE M | director | 6537 0.0003% | $1.74M | 1 | 0 | +1.82% |
| Joly Hubert | director | 5000 0.0002% | $1.33M | 1 | 0 | +5.25% |
| SATCHER DAVID | director | 2491 0.0001% | $663,029.47 | 1 | 0 | +1.73% |
| HEWSON MARILLYN A | director | 3000 0.0001% | $798,510.00 | 1 | 0 | +0.23% |
| WEINBERGER MARK A | director | 1000 0% | $266,170.00 | 1 | 0 | +12.35% |
$1,927,310,793 | 31 | 28.02% | $1,325.87B | |
$364,368,632 | 29 | 9.65% | $36.8B | |
Johnson & Johnson (JNJ) | $6,224,380 | 25 | 3.58% | $640.75B |
$23,541,811 | 22 | 6.43% | $126.14B | |
$28,542,809 | 19 | 26.39% | $505.4B |
| Increased Positions | 2,187 | +46.82% | 82M | +4.66% |
| Decreased Positions | 2,121 | -45.41% | 67M | -3.8% |
| New Positions | 472 | New | 20M | New |
| Sold Out Positions | 117 | Sold Out | 5M | Sold Out |
| Total Postitions | 4,737 | +1.41% | 2B | +0.86% |
| Vanguard Group Inc | $49.06M | 9.82% | 236.62M | -429,273 | -0.18% | 2025-09-30 |
| Blackrock, Inc. | $42.98M | 8.6% | 207.26M | +3M | +1.67% | 2025-09-30 |
| State Street Corp | $27.41M | 5.49% | 132.21M | -591,274 | -0.45% | 2025-09-30 |
| Jpmorgan Chase & Co | $12.16M | 2.43% | 58.64M | +3M | +4.53% | 2025-09-30 |
| Geode Capital Management, Llc | $11.66M | 2.33% | 56.22M | -4M | -7.25% | 2025-09-30 |
| Morgan Stanley | $10M | 2% | 48.23M | +1M | +2.65% | 2025-09-30 |
| Norges Bank | $6.62M | 1.33% | 31.93M | +2M | +5.18% | 2025-06-30 |
| State Farm Mutual Automobile Insurance Co | $6.55M | 1.31% | 31.59M | -84,540 | -0.27% | 2025-09-30 |
| Northern Trust Corp | $6.21M | 1.24% | 29.97M | -360,490 | -1.19% | 2025-09-30 |
| Bank Of America Corp /De/ | $5.89M | 1.18% | 28.42M | +898,834 | +3.27% | 2025-09-30 |